Corpus Intelligence IC Memo — CONWAY REGIONAL REHABILITATION HOSPI 2026-04-26 15:52 UTC
IC Memo — CONWAY REGIONAL REHABILITATION HOSPI
Investment Committee Memorandum | AR | 26 beds | Grade C | EBITDA uplift $499K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CONWAY REGIONAL REHABILITATION HOSPI

CCN 043033 | FAULKNER, AR | 26 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CONWAY REGIONAL REHABILITATION HOSPI is a 26-bed rural/critical access in FAULKNER, AR with $6.6M in net patient revenue and a 11.1% operating margin. The hospital serves a payer mix of 68.8% Medicare, 2.7% Medicaid, and 28.5% commercial.

Thesis: Turnaround. Our ML models identify $499K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.1% to 18.7% (+751bps).

Net Revenue HCRIS$6.6M
Current EBITDA COMPUTED$740K
Operating Margin COMPUTED11.1%
Occupancy HCRIS46.1%
Revenue / Bed COMPUTED$255K
Net-to-Gross HCRIS73.6%
Distress Probability ML56.4%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
52
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 11.1% places it above the state median. Among 52 size-comparable peers (13-52 beds), the median margin is -15.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (13-52), prioritizing same-state peers. 52 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CONWAY REGIONAL REHABILITATION (Target)AR26$6.6M11.1%
ARKANSAS CHILDRENS NORTHWESTAR24$113.6M7.2%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%
ENCORE MEDICAL CENTERAR25$55.7M-4.7%
OZARKS COMMUNITY HOSPITAL OF GAR25$48.6M-21.0%
DREW MEMORIAL HOSPITAL INCAR49$35.3M-27.2%
ASHLEY COUNTY MEDICAL CENTERAR25$33.7M-23.0%
OZARK HEALTH INCAR25$32.3M-4.7%
FORREST CITY MEDICAL CENTERAR48$30.3M-17.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $499K (751bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$139K+210bp18mo
Denial Rate Reduction12.0%6.5%$136K+205bp12mo
Cost to Collect4.5%2.5%$133K+200bp12mo
A/R Days Reduction5200.0%3800.0%$81K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+14bp6mo

5. EBITDA Bridge

Net Collection Rate
$139K
Denial Rate Reduction
$136K
Cost to Collect
$133K
A/R Days Reduction
$81K
Clean Claim Rate
$10K
Total EBITDA Uplift$499K
Current EBITDA$740K
+ RCM Uplift+$499K
Pro Forma EBITDA$1.2M
Current Margin11.1%
Pro Forma Margin18.7%
WC Released (1x)$255K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.1M$9.9M8.67x54.0%
Base (11x exit)10.0x11.0x$1.1M$11.2M9.86x58.0%
Bull Case9.0x11.0x$1.0M$13.2M12.92x66.8%
Bull (12x exit)9.0x12.0x$1.0M$14.7M14.39x70.5%
Bear Case11.0x10.0x$1.3M$7.0M5.59x41.1%
Bear (11x exit)11.0x11.0x$1.3M$8.1M6.48x45.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 68.8% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 56.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 52 hospitals with 13-52 beds
  • Same-state prioritization (n=53)
  • Comp margins: P25=-24.5% / P50=-15.1% / P75=-2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.